医療リスクについて話すことの危険,落とし穴,可能性
S T Bogardus1, E Holmboe, J F Jekel
1Department of Internal Medicine, Yale University School of Medicine, New Haven, Conn 06504, USA. bogardus@gwpo.ynhh.com
JAMA
|March 23, 1999
まとめ
医師は,患者の自主性と情報に基づいた同意を尊重しながら,医療上のリスクを効果的に患者に伝えなければなりません. 定性,定量,グラフィックなどのさまざまな形式を使用することで,患者の治療リスクと利益の理解を向上させることができます.
科学分野:
- 医療倫理 医療倫理について
- 健康に関するコミュニケーション
- 患者教育についてです.
背景:
- 医師は,患者との医療リスクについて話し合い,自主性と情報に基づいた同意を尊重する義務があります.
- 医療リスクの伝達は,知識のギャップ,情報量の不確実性,患者の理解の難しさのために困難です.
- 効果的なリスクコミュニケーションには,介入のリスクと介入しないリスクの両方について議論する必要があります.
研究 の 目的:
- 医療リスク情報の特徴を記述する.
- 患者にリスク情報の伝達における主要な課題を概説する.
- リスク情報を分かりやすい形式で提示する方法を提案する.
主な方法:
- 医学におけるリスクコミュニケーションに関する文献レビュー.
- 複雑な医療情報の伝達における課題の分析.
- 患者のリスクに対する理解を向上させるための戦略の統合.
主要な成果:
- リスク情報には,コミュニケーションを複雑にする固有の特徴があります.
- 主な課題は,医師の知識のギャップと患者の理解の変動性です.
- 質的,定量的,およびグラフィック形式の組み合わせが推奨されます.
結論:
- 医療上のリスクの明確なコミュニケーションは,患者の判断を明確にするために不可欠です.
- 患者の個々のニーズに合わせてコミュニケーション形式を調整することで,理解が向上します.
- リスクコミュニケーションの改善は,信頼できるアドバイザーとしての医師の役割をサポートします.
キーワード:
プロフェッショナル 患者との関係 患者との関係
関連する概念動画
01:26Factors Affecting the Risk of Infection
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
01:26Torts III
Types of Quasi-intentional Torts in Healthcare
Quasi-intentional torts in healthcare involve acts where intent is not directed to harm an individual but results in harm due to careless or reckless speech.
Quasi-intentional torts in healthcare involve acts where intent is not directed to harm an individual but results in harm due to careless or reckless speech.
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
01:26Pharmaceutical Poisoning: Potential Scenarios
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
01:11Hazard Rate
The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
01:12Hazard Ratio
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
For example, in a clinical trial evaluating a...